Predictive role of inflammatory markers for the efficacy of first-line immunotherapy plus chemotherapy in advanced gastric cancer

Abstract Background Immune checkpoint inhibitors (ICIs) plus chemotherapy have become a new first-line treatment option for patients with locally advanced or metastatic gastric cancer. However, it is still controversial whether to choose chemotherapy alone or ICIs plus chemotherapy as the first-line...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenming Zhong, Ying Yuan, Yue Jiang, Guanglei Qiao, Zhoufeng Deng, Zimei Liu, Liping Yu, Hongjian Lin, Jiuang Mao, Lijun Ma, Jianjun Zhang
Format: Article
Language:English
Published: Springer 2025-04-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-01857-0
Tags: Add Tag
No Tags, Be the first to tag this record!